Ginkgo Bioworks
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $49,604 | $48,318 | $43,847 | $89,046 |
Gross Profit | 40,162 | 36,271 | 34,225 | 79,059 |
EBITDA | -65,541 | -68,329 | -143,484 | -35,086 |
EBIT | -81,334 | -83,695 | -159,136 | -52,255 |
Net Income | -60,300 | -90,957 | -107,534 | -56,403 |
Net Change In Cash | 49,604 | 48,318 | 43,847 | 89,046 |
Free Cash Flow | -40,292 | -59,143 | -56,145 | -118,590 |
Cash | 203,566 | 312,420 | 561,572 | 616,214 |
Basic Shares | 54,858 | 54,241 | 51,894 | 52,246 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $227,043 | $251,455 | $477,706 | $313,837 |
Gross Profit | 188,494 | 197,450 | 273,490 | 184,147 |
EBITDA | -484,394 | -821,293 | -2,059,659 | -1,806,673 |
EBIT | -547,414 | -892,847 | -2,121,293 | -1,835,749 |
Net Income | -547,029 | -892,869 | -2,104,929 | -1,830,047 |
Net Change In Cash | 227,043 | 251,455 | 477,706 | 313,837 |
Cost of Revenue | -224,255 | 1,207,070 | ||
Free Cash Flow | -382,126 | -336,301 | -304,469 | -310,339 |
Cash | 561,572 | 944,073 | 1,315,792 | 1,550,004 |
Basic Shares | 51,894 | 48,610 | 41,995 | 34,009 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.10 |
2025-03-31 | -$1.68 |
2024-12-31 | -$2 |
2024-09-30 | -$1.08 |
